User menu

A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma.

Bibliographic reference Frébet, Elise ; Abraham, Julie ; Geneviève, Franck ; Lepelley, Pascale ; Daliphard, Sylvie ; et. al. A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma.. In: Cytometry. Part B: Clinical Cytometry, Vol. 80, no.3, p. 176-85 (2011)
Permanent URL http://hdl.handle.net/2078.1/124494
  1. Swerdlow, Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008)
  2. , Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group, 10.1046/j.1365-2141.2003.04355.x
  3. Hideshima T., Advances in biology of multiple myeloma: clinical applications, 10.1182/blood-2004-01-0037
  4. Craig F. E., Foon K. A., Flow cytometric immunophenotyping for hematologic neoplasms, 10.1182/blood-2007-11-120535
  5. San Miguel J. F., Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome, 10.1182/blood.v99.5.1853
  6. Rawstron A. C., Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantation, 10.1182/blood-2001-12-0297
  7. Robillard N., CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma, 10.1182/blood-2002-11-3333
  8. Bataille, Haematologica, 91, 1234 (2006)
  9. Rawstron A. C., Orfao A., Beksac M., Bezdickova L., Brooimans R. A., Bumbea H., Dalva K., Fuhler G., Gratama J., Hose D., Kovarova L., Lioznov M., Mateo G., Morilla R., Mylin A. K., Omede P., Pellat-Deceunynck C., Andres M. P., Petrucci M., Ruggeri M., Rymkiewicz G., Schmitz A., Schreder M., Seynaeve C., Spacek M., de Tute R. M., Van Valckenborgh E., Weston-Bell N., Owen R. G., San Miguel J. F., Sonneveld P., Johnsen H. E., , Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders, 10.3324/haematol.11080
  10. Paiva, Cytometry B, 78B, 239 (2010)
  11. Arnoulet, Cytometry B, 78B, 4 (2010)
  12. Boyd James, Mathematical tools for demonstrating the clinical usefulness of biochemical markers, 10.3109/00365519709168308
  13. Valleron, Probabilité et Statistique (2001s)
  14. Gachard N., Salviat A., Boutet C., Arnoulet C., Durrieu F., Lenormand B., Lepretre S., Olschwang S., Jardin F., Lafage-Pochitaloff M., Penther D., Sainty D., Reminieras L., Feuillard J., Bene M. C., , Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method, 10.3324/haematol.11622
  15. Perez-Persona E., Vidriales M.-B., Mateo G., Garcia-Sanz R., Mateos M.-V., de Coca A. G., Galende J., Martin-Nunez G., Alonso J. M., de las Heras N., Hernandez J. M., Martin A., Lopez-Berges C., Orfao A., San Miguel J. F., New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells, 10.1182/blood-2007-05-088443
  16. Paiva B., Vidriales M.-B., Cervero J., Mateo G., Perez J. J., Montalban M. A., Sureda A., Montejano L., Gutierrez N. C., de Coca A. G., de las Heras N., Mateos M. V., Lopez-Berges M. C., Garcia-Boyero R., Galende J., Hernandez J., Palomera L., Carrera D., Martinez R., de la Rubia J., Martin A., Blade J., Lahuerta J. J., Orfao A., San Miguel J. F., , Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation, 10.1182/blood-2008-05-159624
  17. Bataille Régis, Pellat-Deceunynck Catherine, Robillard Nelly, Avet-Loiseau Hervé, Harousseau Jean-Luc, Moreau Philippe, CD117 (c-kit) is aberrantly expressed in a subset of MGUS and multiple myeloma with unexpectedly good prognosis, 10.1016/j.leukres.2007.07.016
  18. Ocqueteau, Am J Pathol, 152, 1655 (1998)
  19. Sezer, Haematologica, 86, 837 (2001)
  20. Paiva B., Vidriales M.-B., Mateo G., Perez J. J., Montalban M. A., Sureda A., Montejano L., Gutierrez N. C., Garcia de Coca A., de las Heras N., Mateos M. V., Lopez-Berges M. C., Garcia-Boyero R., Galende J., Hernandez J., Palomera L., Carrera D., Martinez R., de la Rubia J., Martin A., Gonzalez Y., Blade J., Lahuerta J. J., Orfao A., San-Miguel J. F., , The persistence of immunophenotypically normal residual bone marrow plasma cells at diagnosis identifies a good prognostic subgroup of symptomatic multiple myeloma patients, 10.1182/blood-2009-05-221689